Our passion, your health.

Innovation, quality,
internationalization, competitiveness.

These are the leading principles of Fidia Farmaceutici S.p.a., an Italian company.

Principles we are committed to deliver, with our people and ideas, approaching the market with a firm grip on reality and developing value-added solutions to healthcare challenges, which is the demand placed on us.

Find out more

Fidia Presents Hymovis®, a New Generation Hyaluronan, at the ACR Annual Meeting in San Francisco

PARSIPPANY, N.J., Nov. 2, 2015 – Fidia Farmaceutici, a world leader in the research, development and…
Find out more

FDA Approval for Marketing Hymovis in the United States

The FDA’s Center for Devices and Radiological Health (CDRH) has approved the PMA (Pre Market…
Find out more

Italian P&R Group acquires Biofarmitalia and strengthens its leadership in pharmaceutical innovation

Effective October 7th, the P&R SpA Group has completed the acquisition of the Italian based…
Find out more


Find out more about Fidia’s product portfolio:

Go to the website

Fidia worldwide

Direct links to access Fidia’s international websites:

Follow us:

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- advanced wound care
- dermatology
- neurology
- dermo-aesthetics